Shares of Natera, Inc. (NTRA) have traded between $12.52 – 40.92. The next earnings date is set for Mar 10, 2020. Let’s see how its prospects are shaping up.

What does Natera, Inc.(NTRA) do?

Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

NTRA Insider Trading Insight

On 2020-01-14, Rabinowitz Matthew Exec COB sold 127 shares of NTRA. That represents a value of $1,204,973. Not to be outdone, on 2020-01-08, Schueren Robert Alan S – Sale+OE sold8,167 shares of NTRA. These insiders are clearly in the know because they work closely with the company.

The MTZ Consensus Price Target

The mean recommendation of MasTec, Inc. from top Wall Street analysts is a Strong Buy. That is based on 1 analysts who work on the Street. Based on 11 analysts offering 12 month price targets for MasTec in the last 3 months. The average price target is $76.45 with a high forecast of $80.00 and a low forecast of $73.00. The average price target represents a 20.81% increase from the last price of $63.28. Last week, several articles were published in financial papers about MTZ and 40% Bearish while 60% Bullish.

MTZ Intraday Trading

MTZ is due to report earnings on Feb 27, 2020. In the last year the price has ranged from 40.51 – 73.71. Recently, Csiszar Ernst N sold 3,000 shares of MTZ. He is a $352,680 shareholder in MTZ.

Looking for stocks similar to NTRA and MTZ?

Here are some stocks to consider: